| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/17/2007 | US20070111971 Novel compounds |
| 05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 05/16/2007 | EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 05/16/2007 | EP1588145A4 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 05/16/2007 | CN1964965A Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 05/16/2007 | CN1964958A Novel alkyl substituted piperazine derivatives used as monoamine neurotransmitter re-uptake inhibitors |
| 05/16/2007 | CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof |
| 05/16/2007 | CN1962649A Process for synthesizing N-ethyl piperazidine |
| 05/16/2007 | CN1315814C Technique for producing N-formyl morpholine |
| 05/16/2007 | CN1315781C Preparation of 4-amino-1-naphthol ethers |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/10/2007 | WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/10/2007 | WO2007053427A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 05/10/2007 | WO2007053386A2 Processes for the preparation of cyclopropyl-amide derivatives |
| 05/10/2007 | WO2007051920A1 Methanone compounds and the use thereof in pharmaceutical compositions, in particular for treating cardiovascular diseases |
| 05/10/2007 | WO2007051314A1 Curcuminoid compounds for inhibiting plasminogen activator inhibitor-1 |
| 05/10/2007 | WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof |
| 05/10/2007 | WO2005111050A3 Enantioselective phosphoramidite compounds and catalysts |
| 05/10/2007 | US20070105961 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/10/2007 | US20070105870 Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | CA2628210A1 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 05/10/2007 | CA2628187A1 Novel processes for the preparation of cyclopropyl-amide derivatives |
| 05/09/2007 | EP1783115A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 05/09/2007 | EP1782810A2 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 05/09/2007 | EP1781631A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
| 05/09/2007 | EP1781597A1 O-aminophenol derivatives and dyes containing these compounds |
| 05/09/2007 | EP1781297A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 05/08/2007 | CA2366995C Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2325741C Urea derivatives having tnf- .alpha. production inhibitory effects |
| 05/03/2007 | WO2007051095A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/03/2007 | WO2007049579A1 Squarylium compound and photopolymerizable composition for short-wavelength light source using same |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | WO2007048224A1 Iap bir domain binding compounds |
| 05/03/2007 | WO2007012983A3 Process of producing amorolfine |
| 05/03/2007 | WO2006081276A8 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 05/03/2007 | WO2005094896A3 Targeted serotonin reuptake inhibitors |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099079 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | CA2625541A1 Ppar modulating biaromatic compounds |
| 05/03/2007 | CA2624383A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1778679A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 05/02/2007 | EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 05/02/2007 | EP1480963B1 Method for producing 3-amidinophenylalanine derivatives |
| 05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
| 05/02/2007 | EP1299342B1 Method for producing 3,3-diarylpropylamines |
| 05/02/2007 | EP1228052B1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
| 05/02/2007 | CN1956967A Novel amination process |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313072C Cosmetic compositions containing substituted amide derivatives |
| 05/01/2007 | US7211696 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211670 Method for producing 3-amidinophenylalanine derivatives |
| 05/01/2007 | CA2308922C Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 05/01/2007 | CA2138675C Catecholamine surrogates useful as .beta.3 agonists |
| 04/26/2007 | WO2007047737A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | WO2007047431A2 Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
| 04/26/2007 | WO2007045572A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | WO2007045462A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | WO2007017267A3 Novel compounds |
| 04/26/2007 | WO2006135873A3 Parp modulators and treatment of cancer |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | CA2625423A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | CA2625189A1 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | CA2625039A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | CA2624166A1 Inhibitors of viral replication |
| 04/26/2007 | CA2623213A1 Piperazine derivatives as antimalarial agents |
| 04/25/2007 | EP1777219A1 1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776353A1 Method for improving a piperazine colour stability |
| 04/25/2007 | EP1776336A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 04/25/2007 | EP1084269B1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 04/25/2007 | CN1312140C Lipid lowering biphenylcarboxamides |
| 04/24/2007 | US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | US7208496 Substituted heterocyclic compounds |